ITERUM THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.145 USD | -4.58% |
|
-7.66% | -41.88% |
| 06-21 | Sector Update: Health Care Stocks Gain in Late Afternoon | MT |
| 06-21 | Sector Update: Health Care | MT |
Chart calendar Iterum Therapeutics plc
d5.QdhaamwIDMdv0cTG4ImedG4WJ9IrRHzrN7V2mvQkfGw.Nu1tAwB-W68EgJuli8b3AF9cCogGAEioZtoYypJpHx54mSAMIj858Ri6tw~e27b6059f0a195aecebdd42c7bdf853d
Upcoming events on Iterum Therapeutics plc
Past events on Iterum Therapeutics plc
| 19/06/2024 15:00 | Annual General Meeting |
| 16/06/2024 15:00 | American Society for Microbiology Meeting |
| 13/05/2024 13:30 | Q1 2024 Earnings Call |
| 13/05/2024 12:00 | Q1 2024 Earnings Release |
| 28/03/2024 12:30 | Q4 2023 Earnings Call |
| 28/03/2024 11:00 | Q4 2023 Earnings Release |
| 21/03/2024 14:00 | Investor Meeting - H.C. Wainwright |
| 30/01/2024 15:00 | Annual General Meeting |
| 30/01/2024 13:30 | REASSURE Phase 3 Clinical Trial Results Call |
| 14/11/2023 13:30 | Q3 2023 Earnings Call |
| 14/11/2023 12:00 | Q3 2023 Earnings Release |
| 14/10/2023 17:15 | IDWeek Conference - Poster No:2569 |
| 14/10/2023 17:15 | IDWeek Conference - Poster No:2568 |
| 14/10/2023 17:15 | IDWeek Conference - Poster No: 2016 |
| 12/09/2023 05:00 | H.C. Wainwright Global Investment Conference |
| 11/08/2023 13:30 | Q2 2023 Earnings Call |
| 11/08/2023 12:00 | Q2 2023 Earnings Release |
| 01/08/2023 15:00 | Extraordinary Shareholders Meeting |
| 16/06/2023 16:00 | ASM Microbe Conference - AAR-Friday-417 |
| 16/06/2023 16:00 | ASM Microbe Conference - AAR-Friday-401 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,04 0,07 -50.53% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,01 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -102 -105 3.17% | -32,0 -34,3 6.81% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -102 -105 2.47% | -32,1 -34,8 7.6% | -24,5 -24,2 -1.36% | -30,4 -36,5 16.66% | -47,5 -48,0 1.18% | -25,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -103 -106 2.74% | -51,3 -43,5 -17.8% | -90,9 -94,3 3.67% | -44,1 -54,1 18.45% | -37,8 -37,7 -0.09% | -26,5 |
|
Net income Million USD | Released Forecast Spread | -103 -106 2.69% | -52,0 -44,0 -18.26% | -91,6 -94,9 3.52% | -44,4 -54,4 18.27% | -38,4 -38,2 -0.39% | -26,6 |
|
EPS USD | Released Forecast Spread | -106 -109 2.07% | -32,5 -35,7 8.82% | -8,40 -8,55 1.75% | -3,63 -4,44 18.24% | -2,96 -2,96 -0.17% | -1,67 |
| Announcement Date | 12/03/20 | 12/03/21 | 28/03/22 | 16/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,37 -7,50 1.69% | -8,05 -11,0 26.82% | -7,03 -11,2 37.2% | -7,93 -14,0 43.39% | -8,53 -8,70 1.95% | -10,8 -9,20 -17.63% | -16,7 -11,5 -45.09% | -11,4 -12,0 4.74% | -6,16 -10,0 38.55% | -7,09 | -6,07 | -5,76 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,07 -8,68 64.58% | -6,39 -12,2 47.5% | -29,7 -12,2 -143.77% | -4,99 -15,0 66.68% | -9,77 -9,88 1.1% | -12,1 -10,4 -16.2% | -3,72 -11,9 68.71% | -12,2 -12,2 -0.27% | -7,05 -10,2 30.97% | -7,28 | -6,25 | -5,95 |
|
Net income Million USD | Released Forecast Spread | -3,50 -8,73 59.89% | -6,74 -12,2 44.91% | -29,1 -12,2 -138.11% | -5,09 -15,0 66.12% | -9,89 -9,93 0.36% | -12,2 -10,4 -17.44% | -3,88 -11,9 67.49% | -12,4 -12,2 -1.22% | -7,10 -10,2 30.67% | -7,30 | -6,28 | -5,97 |
|
EPS USD | Released Forecast Spread | -0,30 -0,75 60% | -0,60 -1,05 42.86% | -2,38 -1,00 -138% | -0,41 -1,22 66.39% | -0,78 -0,80 2.5% | -0,95 -0,80 -18.75% | -0,30 -0,91 67.03% | -0,94 -0,94 -0.53% | -0,46 -0,73 36.55% | -0,45 | -0,39 | -0,37 |
| Announcement Date | 13/05/22 | 12/08/22 | 10/11/22 | 16/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 28/03/24 | 13/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Iterum Therapeutics plc
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ITRM Stock
- Calendar Iterum Therapeutics plc
